Details

Autor(en) / Beteiligte

• Shuldiner, A R
• Relling, M V
• Peterson, J F
• Hicks, K
• Freimuth, R R
• Sadee, W
• Pereira, N L
• Roden, D M
• Johnson, J A
• Klein, T E

Titel

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation

Ist Teil von

• Clinical pharmacology and therapeutics, 2013-08, Vol.94 (2), p.207-210

Ort / Verlag

Basingstoke: Blackwell Publishing Ltd

Erscheinungsjahr

2013

Link zum Volltext

Quelle

Wiley-Blackwell Journals

Beschreibungen/Notizen

• The pace of discovery of potentially actionable pharmacogenetic variants has increased dramatically in recent years. However, the implementation of this new knowledge for individualized patient care has been slow. The Pharmacogenomics Research Network (PGRN) Translational Pharmacogenetics Program seeks to identify barriers and develop real‐world solutions to implementation of evidence‐based pharmacogenetic tests in diverse health‐care settings. Dissemination of the resulting toolbox of “implementation best practices” will prove useful to a broad audience. Clinical Pharmacology & Therapeutics (2013); 94 2, 207–210. doi:10.1038/clpt.2013.59